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Abstract: Repeated cocaine alters glutamate neurotransmission, in part, by 
reducing cystine-glutamate exchange via system xc-, which maintains 
glutamate levels and receptor stimulation in the extrasynaptic compartment. 
In the present study, we undertook two approaches to determine the 
significance of plasticity involving system xc-. First, we examined whether the 
cysteine prodrug N-acetylcysteine attenuates cocaine-primed reinstatement 
by targeting system xc-. Rats were trained to self-administer cocaine (1 
mg/kg/200 µl, IV) under extended access conditions (6 hr/day). After 
extinction training, cocaine (10 mg/kg, IP) primed reinstatement was 
assessed in rats pretreated with N-acetylcysteine (0–60 mg/kg, IP) in the 
presence or absence of the system xc- inhibitor (S)-4-carboxyphenylglycine 
(CPG; 0.5 µM; infused into the nucleus accumbens). N-acetylcysteine 
attenuated cocaine-primed reinstatement, and this effect was reversed by co-
administration of CPG. Secondly, we examined whether reduced system xc- 
activity is necessary for cocaine-primed reinstatement. To do this, we 
administered N-acetylcysteine (0 or 90 mg/kg, IP) prior to twelve daily self-
administration sessions (1 mg/kg/200 µl, IV; 6 hr/day) since this procedure 
has previously been shown to prevent reduced activity of system xc-. On the 
reinstatement test day, we then acutely impaired system xc- in some of the 
rats by infusing CPG (0.5 µM) into the nucleus accumbens. Rats that had 
received N-acetylcysteine prior to daily self-administration sessions exhibited 
diminished cocaine-primed reinstatement; this effect was reversed by infusing 
the cystine-glutamate exchange inhibitor CPG into the nucleus accumbens. 
Collectively these data establish system xc- in the nucleus accumbens as a 
key mechanism contributing to cocaine-primed reinstatement. 
Keywords: extrasynaptic, nonvesicular, glutamate, microdialysis, cystine-
glutamate antiporter, reinstatement 
Long-term plasticity resulting in altered excitatory 
neurotransmission within corticostriatal pathways has been implicated 
in addiction. Human cocaine abusers exposed to craving-inducing 
stimuli exhibit increased activation of excitatory circuits originating in 
cortical regions, including orbital or prefrontal cortex, and projecting to 
the ventral striatum (Breiter et al., 1997; Dackis and O'Brien, 2005; 
Volkow et al., 2005). Preclinical data indicate that an injection of 
cocaine increases Fos protein expression throughout the corticostriatal 
pathway in rats engaged in cocaine seeking (Neisewander et al., 2000) 
and that transient inactivation of the prefrontal cortex or nucleus 
accumbens core blocks cocaine-primed reinstatement in rats 
(McFarland and Kalivas, 2001). Inhibition of excitatory 
neurotransmission in the nucleus accumbens by preventing activation 
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of corticostriatal pathways, stimulating group II metabotropic 
glutamate autoreceptors, or blocking AMPA receptors also blocks 
cocaine-primed reinstatement in rats (Cornish and Kalivas, 2000; Park 
et al., 2002; Baker et al., 2003; McFarland et al., 2003; Schmidt et 
al., 2005; Peters and Kalivas, 2006). These data indicate that 
regulation of synaptic glutamate represents a novel approach in the 
treatment of cocaine addiction (Volkow and Fowler, 2000; Dackis, 
2004). 
System xc- may be a key mechanism underlying cocaine-
induced changes in glutamate signaling within corticostriatal pathways 
that contribute to pathological cocaine seeking. First, cystine-
glutamate exchange via system xc- supplies nonvesicular glutamate in 
the extrasynaptic compartment that stimulates extrasynaptic group II 
metabotropic glutamate receptors (mGluR) in the nucleus accumbens 
and prefrontal cortex (Baker et al., 2002; Xi et al., 2002a; Moran et 
al., 2005). This is important because stimulation of group II mGluRs 
inhibits synaptic release of glutamate (Baskys and Malenka, 1991; 
Cochilla and Alford, 1998; Schoepp, 2001; Moran et al., 2005). 
Repeated cocaine blunts cystine-glutamate exchange (Baker et al., 
2003; Madayag et al., 2007) which results in reduced basal glutamate 
levels in the nucleus accumbens (Pierce et al., 1996; Reid and Berger, 
1996; Baker et al., 2003), and reduced autoregulation of synaptic 
glutamate by group II mGluRs (Xi et al., 2002b). Likely as a result, a 
cocaine challenge increases synaptic release of glutamate in cocaine-
withdrawn rats (Pierce et al., 1996; Reid and Berger, 1996; Baker et 
al., 2003) that occurs as a result of activation of corticostriatal 
pathways (McFarland et al., 2003). 
Preclinical studies have shown N-acetylcysteine to be effective in 
blocking compulsive drug-seeking in rodents (Baker et al., 2003; 
Madayag et al., 2007; Zhou and Kalivas, 2007) and data from open-
label trials have shown reduced cocaine use and craving in human 
cocaine abusers (Larowe et al., 2006; Mardikian et al., 2007). 
Although the effects of N-acetylcysteine were attributed to increased 
cystine-glutamate exchange by system xc-, data indicate that N-
acetylcysteine may alter glutamate signaling through cellular 
mechanisms distinct from system xc-. Specifically, N-acetylcysteine or 
cysteine resulting from deacetylation of N-acetylcysteine has been 
shown to influence the activity of sodium-dependent glutamate 
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transporters and glutamate receptors including NMDA and AMPA 
receptors (Janaky et al., 2000; Aoyama et al., 2006; Chase et al., 
2007). As a result, the mechanism underlying the effects of N-
acetylcysteine needs to be identified. 
The present study examines the therapeutic potential of 
targeting system xc- to reduce drug-seeking behavior. First, we 
examined whether the cysteine prodrug N-acetylcysteine attenuates 
cocaine-primed reinstatement by targeting system xc-. To do this, we 
examined the capacity of N-acetylcysteine to block cocaine-primed 
reinstatement in the presence or absence of the system xc- inhibitor 
(S)-4-carboxyphenylglycine (Ye et al., 1999; Patel et al., 2004) (CPG; 
0.5 µM; infused into the nucleus accumbens). N-acetylcysteine 
attenuated cocaine-primed reinstatement and this effect was reversed 
by co-administration of CPG. Secondly, we examined whether reduced 
system xc- activity is necessary for cocaine-primed reinstatement. To 
do this, we administered N-acetylcysteine (0 or 90 mg/kg, IP) prior to 
twelve daily self-administration sessions (1 mg/kg, IV; 6 hr/day). This 
procedure has previously been shown to prevent reduced activity of 
system xc- and cocaine-primed reinstatement (Madayag et al., 2007). 
Experimental Procedures 
Subjects 
These experiments utilized male Sprague Dawley rats (Harlan, 
Indianapolis, IN) weighing 275–325 grams upon arrival. Rats were 
individually housed in a temperature-controlled colony room with a 12-
h reversed light/dark cycle. Housing conditions and experimental 
protocols were approved by the Marquette University Institutional 
Animal Care and Use Committee and carried out according to the NIH 
Guide for the Care and Use of Laboratory Animals (revised 1996). 
Surgeries 
Rats included in self-administration studies were implanted with 
indwelling catheters under ketamine HCl (100 mg/kg, IP, Fort Dodge 
Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, IP, Lloyd 
Laboratories, Shenandoah, IA, USA) anesthesia. A silicon tubing 
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catheter (Dow Corning Co., Midland, MI; 0.64 mm ID; 1.19 mm OD) 
was implanted such that it entered the jugular vein through the right 
posterior facial vein and terminated at the right atrium. The catheter 
was sutured to the vein at the entry point. The distal aspect of the 
catheter, which consisted of a 22-gauge guide cannula (Plastics One 
Inc., Roanoke, VA) attached with dental acrylic to a piece of 
polypropylene monofilament surgical mesh (Atrium Medical, Co., 
Hudson, NH), exited 2 cm posterior to the scapulae. Throughout the 
experiment, catheters were filled daily with a heparin solution (83 
i.u./ml; Elkins-Sinn, Inc., Cherry Hill, NJ) and capped when 
disconnected from the leash/delivery line assembly. 
Rats included in microdialysis studies were also implanted with 
indwelling bilateral guide cannulae (20 gauge, 14 mm; Plastics One, 
Roanoke VA) using the following coordinates derived from Paxinos and 
Watson (1986): + 0.9 mm anterior, ± 2.5 mm mediolateral to 
Bregma, and −4.4 mm from the surface of the skull at a 6° angle from 
vertical. The placement of the active region of the microdialysis probe, 
which began 2 mm beyond the ventral tip of the guide cannulae, was 
primarily in the nucleus accumbens core. Following surgery, rats were 
given at least five days to recover prior to testing. During this time, 
rats were provided acetaminophen (480 mg/L) in their drinking water 
and injected daily with a sterile cefazolin antibiotic solution (15 mg, 
IV; West-Ward Pharmaceutical Co., Eatontown, NJ). 
Cocaine Self-Administration Training 
Self-administration occurred in operant chambers (ENV-008CT, 
MED-Associates Inc., St Albans, VT, USA) housed in sound attenuating 
cubicles (ENV-016M, MED-Associates Inc.) and equipped with two 
retractable levers, two stimulus lights, and a water bottle. At least five 
days after surgery, rats were food restricted for 18 hr with water 
available ad libitum. Rats were then placed into the operant chambers 
overnight and responses on the lever designated as active resulted in 
the delivery of food pellets under a fixed ratio 1 schedule of 
reinforcement. Daily food training continued until subjects received at 
least 150 food rewards in a session, which typically occurred following 
the first session. Rats then underwent drug self-administration training 
during daily 2-hr sessions in which operant responses on the active 
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lever were reinforced with an infusion of cocaine (0.5 mg/kg/200 µl IV, 
National Institute on Drug Abuse, Bethesda, MD, USA) under a fixed 
ratio 1 schedule of reinforcement. Each reinforced lever response 
resulted in the illumination of the stimulus light located above the 
active lever and was followed by a 25-s time-out period. Responding 
on a second, inactive lever located on the back wall was recorded but 
had no programmed consequences. Acquisition of cocaine self-
administration was operationally defined as < 10% variation in daily 
responding over at least three consecutive sessions. Once rats met the 
acquisition criteria, they were advanced to maintenance sessions in 
which saline or cocaine was self-administered under extended-access 
conditions (1.0 mg/kg/200 µl IV; 6-hr/day for 12 days). 
Extinction training 
After completing twelve maintenance self-administration 
sessions, rats remained in their home cages for seven days prior to 
extinction training. A seven day delay was used to ensure an adequate 
abstinent period prior to reinstatement, even in rats that quickly 
extinguished responding. Extinction training involved placing rats into 
the operant chambers for 2-hr/day as described above in the self-
administration section except each active lever press now resulted in 
an infusion of saline. This continued until the mean number of lever 
presses was ≤ 10 responses across at least three sessions, at which 
point rats were tested for drug-primed reinstatement. Because the 
average number of extinction sessions needed to meet criteria (± 
SEM) was 15.4 ± 4.3, reinstatement testing occurred on average 22 
days after the last self-administration session. 
Histology 
Rats included in the microdialysis studies were given an 
overdose of pentobarbital (60 mg/kg, IP), and the brains fixed by 
intracardiac infusion of 0.9% saline followed by 2.5% formalin 
solution. Brains were then removed and stored in 2.5 % formalin for at 
least seven days prior to sectioning. The tissue was then blocked and 
coronal sections (100 µM) were cut and stained with cresyl violet to 
verify probe placements. 
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Statistical analyses 
The SPSS statistics package (version 16) was used to perform 
the statistical analyses. Data was analyzed using analysis of variance 
(ANOVA) with drug treatment (e.g., dose of N-acetylcysteine, cocaine 
history) as between subject factors and self-administration session or 
phase of experiment (extinction, reinstatement) as repeated factors. 
Tukeys HSD test were used to analyze significant (p ≤ .05) 
interactions or main effects. Student t-tests were used in instances 
where main effects or simple main effects involving only two groups 
were further analyzed as a result of a significant interaction. 
Experiment 1 
N-acetylcysteine has been shown to block cocaine-primed 
reinstatement in rats that had self-administered under short access 
conditions (Baker et al., 2003). In the present study, we examined 
whether N-acetylcysteine targets cystine-glutamate exchange by 
system xc-to produce this effect. Rats were trained to self-administer 
cocaine as described above under extended access conditions. 
Following extinction training, rats were tested for cocaine-primed 
reinstatement. On the night before the reinstatement test, 
microdialysis probes, constructed as previously described (Baker et al., 
2003), were inserted into indwelling guide cannula. Rats were then 
housed overnight in the self-administration chambers. The next day, 
dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM 
MgCl2, and 0.15% phosphate buffer saline, pH 7.4) was pumped 
through the probes at a rate of 1 µl/min for at least 3 hr. After this, 
vehicle or N-acetylcysteine (30–60 mg/kg, IP) was administered at the 
same time that vehicle or (S)-4 carboxyphenylglycine (CPG; 0.5 µM) 
was added to the dialysis buffer. Sixty minutes later, rats received a 
systemic injection of cocaine (10 mg/kg, IP). The levers were then 
extended into the chambers and responding was monitored for 120 
min. 
Experiment 2 
Repeated cocaine produces a reduction in cystine-glutamate 
exchange from system xc-. In the present study, we explored the 
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contribution of diminished system xc- activity to cocaine-induced 
reinstatement of drug seeking. Rats were trained to self-administer 
cocaine as described above with the exception that rats received saline 
or N-acetylcysteine (90 mg/kg, IP) injections thirty minutes prior to 
each session of cocaine self-administration during both the acquisition 
and maintenance phases. Note, administration of N-acetylcysteine 
prior to daily cocaine self-administration has been shown to prevent 
reduced cystine-glutamate exchange by system xc- (Madayag et al., 
2007). Once self-administration was complete, rats underwent a seven 
day forced abstinence period, which was followed by extinction training 
as described above. On the night before the reinstatement test, 
microdialysis probes, constructed as previously described (Baker et al., 
2003), were inserted into indwelling guide cannula. Rats were then 
housed overnight in the self-administration chambers. The next day, 
dialysis buffer (5 mM glucose, 140 mM NaCl, 1.4 mM CaCl2, 1.2 mM 
MgCl2, and 0.15% phosphate buffer saline, pH 7.4) was pumped 
through the probes at a rate of 1 µl/min for at least 3 hr. After this, 
vehicle or CPG (0.5 µM) was added to the dialysis buffer for the 
duration of the experiment. Sixty minutes later, rats received a 
systemic injection of cocaine (10 mg/kg, IP). The levers were then 
extended into the chambers and responding was monitored for 120 
min. 
Results 
N-acetylcysteine Blocks Cocaine-Primed Reinstatement 
by Targeting System xc- 
In the present study, we tested the hypothesis that N-
acetylcysteine blocks cocaine-induced reinstatement of drug seeking 
by targeting system xc-. Figure 1 illustrates the impact of acute 
administration of N-acetylcysteine in the presence or absence of the 
cystine-glutamate exchange inhibitor CPG on cocaine-primed 
reinstatement of drug seeking. A comparison of lever pressing on the 
last day of extinction or the reinstatement test day produced an 
interaction between day and drug treatment (ANOVA: F4,35=18.949, 
p<.001). Post hoc analyses indicated that administration of the high 
dose of N-acetylcysteine in the absence of cocaine failed to reinstate 
cocaine seeking since there was no increase in lever pressing on the 
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reinstatement test relative to behavior expressed on the last day of 
extinction (Students paired T-test, p<.05). In contrast, a cocaine 
prime reinstated cocaine seeking in all groups, although the magnitude 
of reinstatement was significantly lower in rats treated with either dose 
of N-acetylcysteine when administered in the absence of CPG infusions 
into the nucleus accumbens (Tukey HSD, p<.05). Interestingly, 
infusion of CPG into the nucleus accumbens reversed the effects of 
acute N-acetylcysteine administration such that these rats exhibited 
significantly more lever presses relative to rats pretreated with N-
acetylcysteine in the absence of CPG (Tukey HSD, p<.05). 
 
Figure 1 N-acetylcysteine blocks cocaine-primed reinstatement by targeting 
system xc-. The data depict the mean (+ SEM) number of lever presses on the last 
extinction session or on the reinstatement test day. Drug assignments indicate 
treatment on only the reinstatement test day (N=6–12/group as indicated in the bar 
graphs). N-acetylcysteine (0–60 mg/kg, IP) was injected at the time that (S)-4 
carboxyphenylglycine (CPG; 0–0.5 µM) was added to the dialysis buffer; rats then 
received a cocaine injection (10 mg/kg, IP) sixty min later. The operant levers were 
then extended into the chamber and responding was monitored for 120 min. * 
indicates a significant difference from extinction responding (t-test, p<.05); # 
indicates a significant difference from rats treated with cocaine only (Tukey, p<.05); + 
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indicates a significant increase relative to rats treated with cocaine + N-acetylcysteine 
(60 mg/kg; Tukey, p<.05). 
Decreased cystine-glutamate exchange contributes to 
cocaine-primed reinstatement 
The present study tested the hypothesis that reduced cystine-
glutamate exchange by system xc- is necessary for cocaine-primed 
reinstatement. To do this, N-acetylcysteine was administered prior to 
each daily session of cocaine self-administration, which has previously 
been shown to prevent cocaine-induced plasticity involving system xc- 
(Madayag et al., 2007). In figure 2, we present the impact of daily N-
acetylcysteine on cocaine intake during twelve maintenance sessions 
of cocaine self-administration under extended-access conditions. A 
comparison of the number of cocaine infusions with drug treatment as 
a between subjects variable and time or daily session as a repeated 
measure failed to produce an interaction between the terms (ANOVA: 
F11,264=0.683, p=.754), but produced a significant main effect of time 
(ANOVA: F11,264=8.54, p<.001) and a strong trend toward a main 
effect of drug treatment (ANOVA: F1,24=4.16, p=.053). 
 
Figure 2 N-acetylcysteine reduces cocaine intake across daily sessions of cocaine 
self-administration. Data depict the mean (± SEM) number of cocaine infusions (1.0 
mg/kg/200 µl, IV) obtained during twelve daily maintenance self-administration 
sessions (6-hr/day). Thirty min prior to each daily session, rats received either vehicle 
(1 ml/kg; N=14) or N-acetylcysteine (90 mg/kg, IP; N=12). 
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Figure 3 illustrates the impact of N-acetylcysteine administered 
prior to daily sessions of cocaine self-administration on extinction 
responding following a seven day forced abstinence period. A 
comparison of the number of the number of lever presses with 
pretreatment history as a between subjects variable and day of the 
experiment as a repeated measure failed to produce an interaction 
between the terms (ANOVA: F4,96=0.364, p=.833), but produced a 
significant main effect of time (ANOVA: F4,96=11.95, p<.001) and 
pretreatment history (ANOVA: F1,24=6.165, p=.02). Note, the above 
analyses were conducted on just the first five extinction sessions since 
some rats met the acquisition criteria within five sessions. 
 
Figure 3 N-acetylcysteine pretreatment during self-administration training results 
in lower levels of extinction responding. Following self-administration training, rats 
remained in the home cage for 7 days, and then underwent extinction training in 
which lever presses resulted in a saline infusion. Data depict the mean (± SEM) 
number of lever presses during the first five extinction sessions (2 hr/day). The first 
five sessions are depicted because some rats met the extinction criteria prior to the 
sixth session. Drug assignments indicate treatment during self-administration training 
(N=12–14/group). * indicates a main effect of drug treatment (ANOVA, p<.05). 
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Figure 4 illustrates the impact of the cystine-glutamate 
exchange inhibitor CPG infused into the nucleus accumbens on 
cocaine-primed reinstatement by rats that had received N-
acetylcysteine prior to daily sessions of cocaine self-administration. A 
comparison of lever pressing on the last day of extinction or the 
reinstatement test day produced an interaction between day and drug 
treatment history (ANOVA: F2,22=5.45, p=.012). Analysis of the simple 
main effect comparing response rates on the reinstatement test 
session only yielded a significant effect of drug treatment history 
(ANOVA: F2,22=5.40, p=.012). Post hoc analyses indicated that rats 
that had received N-acetylcysteine prior to daily sessions of cocaine 
self-administration, a procedure previously shown to prevent reduced 
cystine-glutamate exchange (Madayag et al., 2007), exhibited blunted 
cocaine-primed reinstatement (Tukey HSD, p<.05), even though 
testing occurred at least 12 days after the last administration of N-
acetylcysteine (figure 4). Further, acute disruption of cystine-
glutamate exchange following intra-accumbens infusion of CPG in rats 
that had received N-acetylcysteine pretreatments during cocaine self-
administration training restored cocaine-primed reinstatement to levels 
observed in controls that had no history of N-acetylcysteine 
pretreatments (Tukey HSD, p<.05). Although the nucleus accumbens 
was the region primarily infused with CPG, the microdialysis probe for 
some subjects also extended into the striatum dorsal to the nucleus 
accumbens or the olfactory tubercles (figure 5). 
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Figure 4 Acute disruption of cystine-glutamate exchange reverses the impact of 
daily N-acetylcysteine pretreatments on cocaine-primed reinstatement. Data depict 
the mean number of lever presses (± SEM) on the last extinction session or the 
reinstatement test day. Rats had a history of vehicle or N-acetylcysteine 
pretreatments prior to each daily session of cocaine self-administration. On the 
reinstatement test day, rats received intra-accumbens infusions of vehicle or CPG sixty 
min prior to an injection of cocaine (10 mg/kg, IP). The operant levers were then 
extended into the chamber and responding was monitored for 120 min. 
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Figure 5 A schematic illustrating the placement of the 2 mm active membrane 
portion of the microdialysis probe for the rats included in the microdialysis study. The 
active regions of the microdialysis probes were primarily located in the nucleus 
accumbens core, although aspects of nucleus accumbens shell, the striatum dorsal to 
the nucleus accumbens, and the olfactory tubercles were likely sampled as well. 
Discussion 
Plasticity resulting in abnormal activation of corticostrial 
pathways appears to contribute to craving in human drug abusers 
(Breiter et al., 1997; Dackis and O'Brien, 2005; Volkow et al., 2005). 
Previous reports have provided indirect evidence that reduced 
nonvesicular glutamate release by system xc- may contribute to 
cocaine-primed reinstatement (Madayag et al., 2007), and that it 
represents a novel target in the treatment of cocaine addiction (Baker 
et al., 2003; Larowe et al., 2006; Mardikian et al., 2007). In the 
present report, we undertook two approaches to directly examine the 
contribution of system xc- to cocaine-induced reinstatement. First, we 
demonstrate that the cysteine prodrug N-acetylcysteine attenuates 
cocaine-primed reinstatement by targeting system xc-. Second, we 
found that reduced system xc- activity is necessary for robust cocaine-
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primed reinstatement. Collectively, these data establish system xc- in 
the nucleus accumbens as a key mechanism contributing to cocaine-
primed reinstatement and further establish it as a novel target for the 
treatment of cocaine addiction. 
N-acetylcysteine Blunts Cocaine-Induced Reinstatement 
by Targeting System xc- 
Acute administration of N-acetylcysteine blocks cocaine-induced 
reinstatement (Baker et al., 2003), and this was thought to be due to 
increased cystine-glutamate exchange. However, recent data indicate 
that N-acetylcysteine may block reinstatement by targeting sites other 
than cystine-glutamate exchange. Specifically, N-acetylcysteine or 
cysteine resulting from deacetylation of N-acetylcysteine has been 
shown to regulate the activity of sodium-dependent glutamate 
transporters, NMDA receptors, and AMPA receptors (Janaky et al., 
2000; Aoyama et al., 2006; Chase et al., 2007). In the present study, 
we replicate finding that acute administration of N-acetylcysteine 
attenuates cocaine-primed reinstatement when administered prior to a 
cocaine injection. Moreover, we found that this effect is blocked by 
infusion of the cystine-glutamate exchange inhibitor CPG into the 
nucleus accumbens. Because CPG also acts at metabotropic glutamate 
receptors, we selected a concentration (500 nM) that is significantly 
lower than the EC50s of CPG to block group I mGluRs (40–65 µM) or 
stimulate group II mGluRs (570–970 µM) (Cavanni et al., 1994; 
Thomsen et al., 1994; Sekiyama et al., 1996). As a result, the present 
findings indicate that N-acetylcysteine blocks cocaine-induced 
reinstatement of drug seeking by targeting cystine-glutamate 
exchange by system xc- in the nucleus accumbens. 
It is noteworthy that blockade of reinstatement by N-
acetylcysteine in the present study occurred in rats trained to self-
administer cocaine under extended-access conditions, which has been 
suggested to represent a more stringent test of the therapeutic 
potential (Ahmed and Koob, 1998; Mantsch et al., 2004; Kippin et al., 
2006). Further, these data are consistent with the findings of recent 
open-label trials demonstrating reduced cocaine craving and use in 
human cocaine abusers receiving N-acetylcysteine (Larowe et al., 
2006; Mardikian et al., 2007). Although clinical trials are needed to 
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more stringently determine the anticraving efficacy of N-
acetylcysteine, these data establish, to at least some degree, 
predictive validity for the reinstatement paradigm as a screen for novel 
pharmacotherapies for addiction. 
Administration of N-acetylcysteine prior to daily sessions of 
cocaine self-administration under extended access conditions has 
previously been shown to prevent escalation of drug intake (Madayag 
et al., 2007). In the present report, we obtained a significant increase 
in drug intake regardless of N-acetylcysteine pretreatment. Differences 
between the two studies include dose of N-acetylcysteine, number of 
self-administration sessions, and subjects per group. The latter may be 
particularly important because the present study obtained a strong, 
but nonsignificant trend towards N-acetylcysteine-induced blockade of 
escalation (p=.053). Further, the magnitude of escalation observed in 
the control subjects of the present study was larger than we previously 
obtained. Collectively, additional data may be needed to determine the 
role of cystine-glutamate exchange in the emergence of escalation of 
drug intake. 
It may seem counterintuitive that increased glutamate release 
from system xc- reduces cocaine-induced behaviors in rodents and 
drug-craving and use in humans that are thought to be dependent, at 
least in part, on glutamate signaling (Cornish and Kalivas, 2000; Baker 
et al., 2003; Di Ciano and Everitt, 2003; McFarland et al., 2003; 
Larowe et al., 2006). However, this may reflect the existence of 
multiple, functionally-distinct pools of glutamate. Cocaine increases 
glutamate in the synaptic cleft following corticostriatal activation 
thereby generating behaviors dependent upon postsynaptic receptor 
stimulation (Cornish and Kalivas, 2000; McFarland et al., 2003; Di 
Ciano and Everitt, 2004; Suto et al., 2004). System xc- releases 
glutamate into the extrasynaptic compartment resulting in the 
stimulation of group II mGluRs (Baker et al., 2002; Baker et al., 2003; 
Moran et al., 2005). By stimulating extrasynaptic group II mGluRs 
without exerting postsynaptic effects, extrasynaptic glutamate appears 
to inhibit synaptic release (Baker et al., 2002; Moran et al., 2005). 
Sodium-dependent glutamate transporters may partition the two pools 
by limiting glutamate overflow from the synapse into the extrasynaptic 
compartment (Danbolt, 2001), and restricting entry of nonvesicular 
glutamate into the synapse (Jabaudon et al., 1999). To the extent that 
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NR2B receptors are located outside the synapse, this hypothesis is 
supported by the recent observation that glutamate release from 
astrocytes appears to stimulate extrasynaptic, but not synaptic NMDA 
receptors (D'Ascenzo et al., 2007). 
Targeting system xc- to prevent plasticity involving 
extracellular glutamate 
Cocaine-induced seeking in rodents and use in humans arises, 
at least in part, as a result of corticostriatal circuits that are rendered 
overactive as a result of drug-induced plasticity (Breiter et al., 1997; 
Volkow et al., 1999; Park et al., 2002; McFarland et al., 2003; Schmidt 
et al., 2005; Volkow et al., 2005). Reduced cystine-glutamate 
exchange may contribute to this process since it provides endogenous 
tone to group II mGluRs that function to inhibit synaptic release 
(Baskys and Malenka, 1991; Cochilla and Alford, 1998; Schoepp, 
2001; Moran et al., 2005). Further, repeated cocaine produces a 
persistent decrease in cystine-glutamate exchange by system xc- in 
the nucleus accumbens (Baker et al., 2003; Madayag et al., 2007), 
and these changes may be necessary for cocaine-induced behavioral 
plasticity used to model aspects of addiction. In support, we have 
previously shown that the cysteine prodrug N-acetylcysteine 
administered prior to daily sessions of cocaine self-administration or 
experimenter-delivered cocaine prevents plasticity involving system 
xc-, escalation of drug intake, behavioral sensitization, and cocaine-
primed reinstatement (Madayag et al., 2007). Further, in the present 
study, rats pretreated with N-acetylcysteine prior to daily cocaine self-
administration show a strong trend toward blunted cocaine intake, 
reduced extinction responding, and lower levels of cocaine seeking 
following a cocaine prime. These findings are similar to an earlier 
report that administration of daily N-acetylcysteine after heroin self-
administration but before extinction training resulted in blunted heroin 
seeking during extinction and reinstatement testing (Zhou and Kalivas, 
2007). Interestingly, acute disruption of system xc- following infusion 
of the cystine-glutamate exchange inhibitor CPG into the nucleus 
accumbens during the test for cocaine-primed reinstatement restored 
cocaine seeking to the level observed in cocaine control rats that had 
not received N-acetylcysteine prior to daily sessions of cocaine self-
administration. Collectively these data support the hypothesis that 
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reduced system xc- activity promotes the capacity of a cocaine prime 
to elicit cocaine seeking. 
Additional work is needed to understand how N-acetylcysteine is 
preventing plasticity involving system xc-. First, N-acetylcysteine may 
maintain normal levels of cystine-glutamate exchange, which then 
prevents cocaine-induced synaptic glutamate release by providing 
normal tone on group II mGluRs. Thus, CPG may have restored 
reinstatement by transiently lowering basal glutamate levels and 
reducing tone on group II mGluRs resulting in an enhanced glutamate 
response following a cocaine challenge. Alternatively, repeated N-
acetylcysteine may have decreased the magnitude of cocaine 
reinstatement by reducing cocaine intake. In support, earlier studies 
have revealed a correlation between cocaine intake and magnitude of 
cocaine-primed reinstatement (Sutton et al., 2000; Baker et al., 
2001). However, N-acetylcysteine pretreatment prior to daily sessions 
of cocaine self administration under short-access conditions in our 
earlier report did not result in lower cocaine intake, but still resulted in 
blunted cocaine-induced reinstatement (Madayag et al., 2007). 
Likewise, this approach also reduced behavioral sensitization in the 
absence of altered cocaine intake (Madayag et al., 2007). 
Interestingly, repeated N-acetylcysteine administered after heroin self-
administration resulted in reduced extinction responding (Zhou and 
Kalivas, 2007). Lastly, the effects of daily N-acetylcysteine 
pretreatment were reversed by producing an acute disruption of 
cystine-glutamate exchange in the present study. 
Conclusion 
These data reveal that acute administration of N-acetylcysteine 
targets system xc- to block cocaine primed reinstatement in rats 
withdrawn from extended-access cocaine self-administration. Further, 
reduced cystine-glutamate exchange appears to be necessary for 
cocaine primed reinstatement. Collectively, these data provide further 
support for cysteine prodrugs, including N-acetylcysteine, as potential 
treatments for cocaine addiction by demonstrating efficacy after acute 
and repeated administration. Further, it establishes system xc- as a 
novel mechanism that likely contributes to plasticity rendering 
corticostriatal pathways overactive. This is of particular interest 
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because it is consistent with the concept that a mechanism releasing 
nonvesicular glutamate from glial cells into an extrasynaptic 
compartment contributes to pathological glutamate signaling. 
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